Skip to main content
. Author manuscript; available in PMC: 2008 Feb 4.
Published in final edited form as: J Immunother. 2004;27(6):472–477. doi: 10.1097/00002371-200411000-00007

TABLE 3.

Example of a Positive 12-Day IVS Assay for Peptide Recognition

# of Vaccinations
Stimulus 0 2 4
pg/ml IFN-γ
T2/ESO-1 (N) 380 2896 2723
T2/ESO-1 (9V) 309 2994 2554
T2/gp 100:180-188 234 45 22
Unpulsed T2 282 57 20
624mel (A2+, ESO-1+) 105 21 10
1363mel (A2+, ESO-1+) 83 62 20
624.28mel (A2−, ESO-1+) 41 15 1
526mel (A2+, ESO-1−) 29 5 0
None 124 27 15

ESO-1(N), native NY-ESO-1:157-165 peptide; ESO-1(9V), modified peptide NY-ESO-1:157-165(9V); gp100:180-188, irrelevant peptide.